Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
SRRA | Sierra Oncology, Inc. | Aggarwal Gaurav | Director | Jul 01, 2022 | Option Exercise | $55.00 | 2,735,853 | 150,471,915 | 0 | Jul 01, 2022, 04:45 PM | |
SRRA | Sierra Oncology, Inc. | Aggarwal Gaurav | Director | Jan 31, 2022 | Buy | $27.00 | 800,000 | 21,600,000 | 2,735,853 | Jan 31, 2022, 06:47 PM | |
SRRA | Sierra Oncology, Inc. | Aggarwal Gaurav | Director | Jan 26, 2022 | Option Exercise | $13.20 | 480,277 | 6,339,656 | 1,935,853 | Jan 28, 2022, 07:53 PM | |
OCRX | Ocera Therapeutics, Inc. | Aggarwal Gaurav | Chief Business Officer | Jan 15, 2016 | Buy | $2.15 | 10,000 | 21,500 | 20,000 | Jan 19, 2016, 08:14 AM | |
OCRX | Ocera Therapeutics, Inc. | Aggarwal Gaurav | Chief Business Officer | May 06, 2015 | Buy | $3.62 | 7,500 | 27,150 | 10,000 | May 06, 2015, 06:02 PM | |
HPTX | HYPERION THERAPEUTICS INC | Aggarwal Gaurav | Director | Jul 31, 2012 | Buy | $10.00 | 5,000 | 50,000 | 5,000 | Aug 02, 2012, 12:29 PM |